CLINICAL_TRIALS
trial_result
· 2012-05-31
Clinical Trial Update: Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU) [Phase 3]
Summary
A Phase 3 trial comparing 5 mg versus 20 mg desloratadine in chronic urticaria has completed, assessing dosing effects on skin lesions.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Charite University, Berlin, Germany | Conditions: Chronic Urticaria | Phase 3 | Status: COMPLETED